Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 2 Active
-
3D BM for NK-AML interaction: Mimicking the bone marrow niche - 3D culture as a new tool to improve NK cell-based immunotherapies for AML
Witalisz-Siepracka, A. (PI) & Summer, S. (CoPI)
Gesellschaft für Forschungsförderung NÖ (GFF)
01.07.2025 → 30.06.2028
Project: Funded Research
-
Breast Cancer: Uncovering new checkpoints in natural killer cells to prevent breast cancer metastasis
Witalisz-Siepracka, A. (PI), Vallet, S. (CoPI) & Gotthardt, D. (CoPI)
Gesellschaft für Forschungsförderung NÖ (GFF)
01.12.2022 → 30.11.2026
Project: Funded Research
Research output
-
Dissecting the Role of Type I and Type II Interferon Signaling in Acute Myeloid Leukemia
Edtmayer, S. R. (Presenter), Zdarsky, B., Witalisz-Siepracka, A. & Stoiber, D., Feb 2026.Research output: Contribution to conference › Poster at a conference
-
Revealing an unconventional JAK1/2-STAT3 branch in macrophage IFN-γ signaling
Botman, M., Huisman, J. M. A., Drakaki, A., Maas, S. L., Witalisz-Siepracka, A., Stoiber, D., van der Vorst, E. P. C., Siebeler, R. & Hoeksema, M. A., 24 Feb 2026, In: Cell Reports. 45, 2, p. 116985 1 p., 116985.Research output: Journal article (peer-reviewed) › Journal article
Open Access -
Triple-Negative Breast Tumours Induce Functional Impairment of Peripheral Natural Killer Cells
Harm, T. (Presenter), Witalisz-Siepracka, A. & Stoiber, D., Feb 2026.Research output: Contribution to conference › Poster at a conference
-
Atovaquone and selinexor as a novel combination treatment option in acute myeloid leukemia
Weiss, S., Zdársky, B., Witalisz-Siepracka, A., Edtmayer, S., Holzer, A., Heindl, K., Casanova, E., Podar, K. & Stoiber, D., 31 Mar 2025, In: Cancer Letters. 613, p. 217501 217501.Research output: Journal article (peer-reviewed) › Journal article
Open Access1 Link opens in a new tab Citation (Scopus) -
Cell-type-specific requirement for TYK2 in murine immune cells under steady state and challenged conditions
Karjalainen, A., Witalisz-Siepracka, A., Prchal-Murphy, M., Martin, D., Sternberg, F., Krunic, M., Dolezal, M., Fortelny, N., Farlik, M., Macho-Maschler, S., Lassnig, C., Meissl, K., Amenitsch, L., Lederer, T., Pohl, E., Gotthardt, D., Bock, C., Decker, T., Strobl, B. & Müller, M., Dec 2025, In: Cellular and Molecular Life Sciences. 82, 1, p. 98 98.Research output: Journal article (peer-reviewed) › Journal article
Open Access3 Link opens in a new tab Citations (Scopus)
Prizes
Activities
-
Phosphatase PROTAC degrader drugs in ALCL: Two-pronged strategy to tumour eradication
Merkel, O. (Participant), Witalisz-Siepracka, A. (Organiser) & Stanika, R. (Organiser)
13 May 2026Activity: Participating in/organising an event › Organising an event (Science to science)
-
Strategies towards culturing stem cells under physiological conditions
Kasper, C. (Speaker), Witalisz-Siepracka, A. (Organiser) & Stanika, R. (Organiser)
06 May 2026Activity: Participating in/organising an event › Organising an event (Science to science)
-
A rare midbrain-derived cell type populates the mouse somatosensory thalamus to provide strong inhibitory control of the ascending trigeminal pathway
Delogu, A. (Speaker), Witalisz-Siepracka, A. (Organiser) & Stanika, R. (Organiser)
04 Mar 2026Activity: Participating in/organising an event › Organising an event (Science to science)
-
Triple-Negative Breast Tumours Induce Functional Impairment of Peripheral Natural Killer Cells
Harm, T. (Speaker), Witalisz-Siepracka, A. (Co-Author) & Stoiber-Sakaguchi, D. (Co-Author)
19 Feb 2026Activity: Talk or presentation › Science to science: (Invited) talk/oral presentation
-
Deciphering genetic predictors of drug response across cancer
Schmoellerl, J. (Speaker), Witalisz-Siepracka, A. (Organiser) & Haddad, S. (Organiser)
28 Jan 2026Activity: Participating in/organising an event › Organising an event (Science to science)
Press/Media
-
Die Killerzellen kämpfen lassen
28.05.2024
1 item of Media coverage
Press/Media: Newspaper/magazine › Online
-
60 Sekunden mit Agnieszka Witalisz | Krebsforschung
12.01.2024
1 item of Media coverage
Press/Media: Social media/Blog